Literature DB >> 27773718

Inhibition of p38 mitogen-activated protein kinases attenuates renal interstitial fibrosis in a murine unilateral ureteral occlusion model.

Fang Gao1, Yanping Wang2, Shulin Li2, Zhuojun Wang2, Caixia Liu2, Dong Sun3.   

Abstract

AIMS: Cellular hypoxia has been proposed as a major factor contributing to the pathogenesis of chronic renal injury. Much of our understanding of how mitogen-activated protein kinases (MAPK) signaling promotes renal fibrosis has been based on cell culture studies. Therefore, we used the unilateral ureteral occlusion (UUO) model to further elucidate the role of the p38 MAPK pathway in renal interstitial fibrosis induced by hypoxia.
MATERIALS AND METHODS: In the present study, 24 male mice were randomized into the following three groups (n=8 each): Sham group (DMSO solution), UUO group (UUO+DMSO solution) and UP group (UUO+p38 inhibitor). The model of UUO was conducted using an established procedure described previously. Histological changes in renal tubular interstitium were observed with hematoxylin-eosin (HE) and Masson's trichrome. The protein levels of hypoxia inducible factor-1α (HIF-1α)、transforming growth factor-β1 (TGF-β1), connective tissue growth factor (CTGF) and collagen type I were analyzed by western blotting and immunohistochemistry at 2weeks. KEY
FINDINGS: Increased expression of hypoxia inducible factor-1α (HIF-1α) in UUO mice confirmed the existence of hypoxia in renal interstitial. Hypoxia result in tubulointerstitial fibrosis via the molecular activation of connective tissue growth factor (CTGF). p38 inhibitor administration markedly downregulates the protein of connective tissue growth factor (CTGF) and collagen type I expression induced by hypoxia. SIGNIFICANCE: An increase in p38 MAPK activation is induced by hypoxia. The hypoxia up-regulates the protein connective tissue growth factor (CTGF) and collagen I expression in a p38-dependent manner. Copyright Â
© 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Interstitial fibrosis; Kidney; Unilateral ureteral occlusion; p38 MAPK

Mesh:

Substances:

Year:  2016        PMID: 27773718     DOI: 10.1016/j.lfs.2016.10.022

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  9 in total

1.  Resveratrol suppresses the myofibroblastic phenotype and fibrosis formation in kidneys via proliferation-related signalling pathways.

Authors:  Xing Zhang; Hong Lu; Shuangshuang Xie; Cunzao Wu; Yangyang Guo; Yanyi Xiao; Shizhang Zheng; Hengyue Zhu; Yan Zhang; Yongheng Bai
Journal:  Br J Pharmacol       Date:  2019-11-28       Impact factor: 8.739

2.  Bone marrow‑derived mesenchymal stem cell‑conditioned medium attenuates tubulointerstitial fibrosis by inhibiting monocyte mobilization in an irreversible model of unilateral ureteral obstruction.

Authors:  Jiarong Zheng; Qinghua Wang; Weixue Leng; Xia Sun; Jun Peng
Journal:  Mol Med Rep       Date:  2018-04-05       Impact factor: 2.952

3.  The family of 14-3-3 proteins and specifically 14-3-3σ are up-regulated during the development of renal pathologies.

Authors:  Myrto Rizou; Eleni A Frangou; Filio Marineli; Niki Prakoura; Jerome Zoidakis; Harikleia Gakiopoulou; George Liapis; Panagiotis Kavvadas; Christos Chatziantoniou; Manousos Makridakis; Antonia Vlahou; John Boletis; Demetrios Vlahakos; Dimitrios Goumenos; Evgenios Daphnis; Christos Iatrou; Aristidis S Charonis
Journal:  J Cell Mol Med       Date:  2018-06-28       Impact factor: 5.310

4.  Renal tubular epithelial cells: the neglected mediator of tubulointerstitial fibrosis after injury.

Authors:  Ruochen Qi; Cheng Yang
Journal:  Cell Death Dis       Date:  2018-11-13       Impact factor: 8.469

Review 5.  Artemisinin and artemisinin derivatives as anti-fibrotic therapeutics.

Authors:  David Dolivo; Pamela Weathers; Tanja Dominko
Journal:  Acta Pharm Sin B       Date:  2020-09-08       Impact factor: 11.413

6.  A single-domain i-body, AD-114, attenuates renal fibrosis through blockade of CXCR4.

Authors:  Qinghua Cao; Chunling Huang; Hao Yi; Anthony J Gill; Angela Chou; Michael Foley; Chris G Hosking; Kevin K Lim; Cristina F Triffon; Ying Shi; Xin-Ming Chen; Carol A Pollock
Journal:  JCI Insight       Date:  2022-02-22

Review 7.  Epithelial-mesenchymal transition in organ fibrosis development: current understanding and treatment strategies.

Authors:  Lexin Liu; Qizhe Sun; Frank Davis; Jianhua Mao; Hailin Zhao; Daqing Ma
Journal:  Burns Trauma       Date:  2022-04-08

8.  MicroRNA miR-4709-3p targets Large Tumor Suppressor Kinase 2 (LATS2) and induces obstructive renal fibrosis through Hippo signaling.

Authors:  Zexiang Jiang; Weiping Xia; Guoyu Dai; Bo Zhang; Yang Li; Xiang Chen
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

9.  Crosstalk between mitogen-activated protein kinase inhibitors and transforming growth factor-β signaling results in variable activation of human dermal fibroblasts.

Authors:  David M Dolivo; Sara A Larson; Tanja Dominko
Journal:  Int J Mol Med       Date:  2018-10-23       Impact factor: 4.101

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.